OBJECTIVE: Exposure to microorganisms has repeatedly been found to influence development of atopic diseases, such as asthma. Innovative techniques have been developed that can comprehensively characterize microbial communities. The objective of this study was to characterize the home microbiota of asthmatic children utilizing 16S rRNA-based phylogenetic analysis by microarray. METHODS: In this cross-sectional study, DNA was extracted from home dust and bacterial 16S rRNA genes amplified. Bacterial products were hybridized to the PhyloChip Array and scanned using a GeneArray scanner (Affymetrix, Santa Clara, CA). The Adonis test was used to determine significant differences in the whole microbiome. Welch's t-test was used to determine significant abundance differences and genus-level richness differences. RESULTS: Nineteen homes were included in the analysis (14 asthma and five no asthma). About 1741 operational taxonomic units (OTUs) were found in at least one sample. Bacterial genus richness did not differ in the homes of asthmatics and non-asthmatics (p = 0.09). The microbial profile was significantly different between the two groups (p = 0.025). All the top 12 OTUs with significant abundance differences were increased in homes of asthmatics and belonged to one of the five phyla (p = 0.001 to p = 7.2 × 10(-6)). Nearly half of significant abundance differences belonged to the phylum Cyanobacteria or Proteobacteria. CONCLUSIONS: These results suggest that home dust has a characteristic microbiota which is disturbed in the homes of asthmatics, resulting in a particular abundance of Cyanobacteria and Proteobacteria. Further investigations are needed which utilize high-throughput technology to further clarify how home microbial exposures influence human health and disease.
OBJECTIVE: Exposure to microorganisms has repeatedly been found to influence development of atopic diseases, such as asthma. Innovative techniques have been developed that can comprehensively characterize microbial communities. The objective of this study was to characterize the home microbiota of asthmatic children utilizing 16S rRNA-based phylogenetic analysis by microarray. METHODS: In this cross-sectional study, DNA was extracted from home dust and bacterial 16S rRNA genes amplified. Bacterial products were hybridized to the PhyloChip Array and scanned using a GeneArray scanner (Affymetrix, Santa Clara, CA). The Adonis test was used to determine significant differences in the whole microbiome. Welch's t-test was used to determine significant abundance differences and genus-level richness differences. RESULTS: Nineteen homes were included in the analysis (14 asthma and five no asthma). About 1741 operational taxonomic units (OTUs) were found in at least one sample. Bacterial genus richness did not differ in the homes of asthmatics and non-asthmatics (p = 0.09). The microbial profile was significantly different between the two groups (p = 0.025). All the top 12 OTUs with significant abundance differences were increased in homes of asthmatics and belonged to one of the five phyla (p = 0.001 to p = 7.2 × 10(-6)). Nearly half of significant abundance differences belonged to the phylum Cyanobacteria or Proteobacteria. CONCLUSIONS: These results suggest that home dust has a characteristic microbiota which is disturbed in the homes of asthmatics, resulting in a particular abundance of Cyanobacteria and Proteobacteria. Further investigations are needed which utilize high-throughput technology to further clarify how home microbial exposures influence human health and disease.
Entities:
Keywords:
Built environment; cyanobacteria; damp environments; microbiome; pediatrics
Authors: Markus J Ege; Melanie Mayer; Anne-Cécile Normand; Jon Genuneit; William O C M Cookson; Charlotte Braun-Fahrländer; Dick Heederik; Renaud Piarroux; Erika von Mutius Journal: N Engl J Med Date: 2011-02-24 Impact factor: 91.245
Authors: Cristina E Mapp; Anthony A Fryer; Nicoletta De Marzo; Valeria Pozzato; Michele Padoan; Piera Boschetto; Richard C Strange; Anja Hemmingsen; Monica A Spiteri Journal: J Allergy Clin Immunol Date: 2002-05 Impact factor: 10.793
Authors: Magali Noval Rivas; Oliver T Burton; Petra Wise; Yu-qian Zhang; Suejy A Hobson; Maria Garcia Lloret; Christel Chehoud; Justin Kuczynski; Todd DeSantis; Janet Warrington; Embriette R Hyde; Joseph F Petrosino; Georg K Gerber; Lynn Bry; Hans C Oettgen; Sarkis K Mazmanian; Talal A Chatila Journal: J Allergy Clin Immunol Date: 2012-11-30 Impact factor: 10.793
Authors: Charles S Barnes; Kevin Kennedy; Luke Gard; Erika Forrest; Linda Johnson; Freddy Pacheco; Frank Hu; Mercedes Amado; Jay M Portnoy Journal: Allergy Asthma Proc Date: 2008-03-11 Impact factor: 2.587
Authors: Anirudra Parajuli; Mira Grönroos; Sari Kauppi; Tomasz Płociniczak; Marja I Roslund; Polina Galitskaya; Olli H Laitinen; Heikki Hyöty; Ari Jumpponen; Rauni Strömmer; Martin Romantschuk; Nan Hui; Aki Sinkkonen Journal: PLoS One Date: 2017-11-16 Impact factor: 3.240
Authors: Patrick F Horve; Savanna Lloyd; Gwynne A Mhuireach; Leslie Dietz; Mark Fretz; Georgia MacCrone; Kevin Van Den Wymelenberg; Suzanne L Ishaq Journal: J Expo Sci Environ Epidemiol Date: 2019-07-15 Impact factor: 5.563
Authors: Suzanne L Ishaq; Maurisa Rapp; Risa Byerly; Loretta S McClellan; Maya R O'Boyle; Anika Nykanen; Patrick J Fuller; Calvin Aas; Jude M Stone; Sean Killpatrick; Manami M Uptegrove; Alex Vischer; Hannah Wolf; Fiona Smallman; Houston Eymann; Simon Narode; Ellee Stapleton; Camille C Cioffi; Hannah F Tavalire Journal: PLoS Biol Date: 2019-11-26 Impact factor: 8.029
Authors: Balamuralikrishna Jayaprakash; Rachel I Adams; Pirkka Kirjavainen; Anne Karvonen; Asko Vepsäläinen; Maria Valkonen; Kati Järvi; Michael Sulyok; Juha Pekkanen; Anne Hyvärinen; Martin Täubel Journal: Microbiome Date: 2017-10-13 Impact factor: 14.650